New research indicates that supplementation with omega-3 fatty acids and co-enzyme Q10 (CoQ10) may reduce levels of prostate-specific antigen (PSA), a protein that suggests an increased risk of prostate cancer. The recent study included 504 healthy men with serum PSA levels lower or equal to 2.5 nanograms per milliliter. The participants were randomly assigned to one of four groups. Each group corresponded to a different supplement, either omega-6 fatty acids, omega-3 fatty acids, CoQ10 or placebo. Read more here.
Study mentioned: Safarinejad MR, et al. Effects of EPA, γ-linolenic acid or coenzyme Q10 on serum prostate-specific antigen levels: a randomised, double-blind trial. Br J Nutr. 2012 Nov 30:1-8. [Epub ahead of print] PMID: 23199523
No comments:
Post a Comment